We prepared the precursor solutions by carrying out one-pot syntheses. 10 mmol of tin (IV) chloride pentahydrate (SnCl4∙5H2O, 98%) and 0.5 mmol of antimony (III) chloride (SbCl3, >99.0%) were added to 10 ml of 2-methoxy ethanol (≥99.9%). Dopants (M) were added in the form of the transition metal nitrate n-hydrate (TM(NO3)x∙nH2O) in desired amounts that were determined by calculating the mole fraction of the metal dopant according to the equation (moles of TM)/((moles of TM) + (moles of Sn)). Specifically, Cr(NO3)3·9H2O (99%), Mn(NO3)2·xH2O (98%), Fe(NO3)3·9H2O (98%), and Co(NO3)2·6H2O (≥98%) were used as dopants. All substances were purchased from Sigma Aldrich. Precursor solutions were stirred for 10 minutes. L-cysteine (Sigma Aldrich, 97% purity), and Nafion (Sigma Aldrich, 5 wt% in a low-molecular-weight aliphatic alcohol and water) were purchased from Sigma-Aldrich. Phosphate-buffered saline (PBS) tablets were purchased from Gibco.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.